SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-08-006420
Filing Date
2008-05-12
Accepted
2008-05-12 16:58:44
Documents
10
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2185347z10-q.htm 10-Q 345547
2 EXHIBIT 10.1 a2185347zex-10_1.htm EX-10.1 37821
3 EXHIBIT 10.2 a2185347zex-10_2.htm EX-10.2 37662
4 EXHIBIT 10.3 a2185347zex-10_3.htm EX-10.3 37570
5 EXHIBIT 10.4 a2185347zex-10_4.htm EX-10.4 41551
6 EXHIBIT 10.5 a2185347zex-10_5.htm EX-10.5 42167
7 EXHIBIT 10.6 a2185347zex-10_6.htm EX-10.6 2102
8 EXHIBIT 31.1 a2185347zex-31_1.htm EX-31.1 6917
9 EXHIBI 31.2 a2185347zex-31_2.htm EX-31.2 6907
10 EXHIBIT 32.1 a2185347zex-32_1.htm EX-32.1 3699
  Complete submission text file 0001047469-08-006420.txt   563241
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 08824368
SIC: 2834 Pharmaceutical Preparations